310 related articles for article (PubMed ID: 20607622)
1. Sphingolipids in multiple sclerosis.
Jana A; Pahan K
Neuromolecular Med; 2010 Dec; 12(4):351-61. PubMed ID: 20607622
[TBL] [Abstract][Full Text] [Related]
2. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.
Jana A; Hogan EL; Pahan K
J Neurol Sci; 2009 Mar; 278(1-2):5-15. PubMed ID: 19147160
[TBL] [Abstract][Full Text] [Related]
3. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
[TBL] [Abstract][Full Text] [Related]
4. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.
Podbielska M; Krotkiewski H; Hogan EL
Neurochem Res; 2012 Jun; 37(6):1154-69. PubMed ID: 22451227
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.
Miller LG; Young JA; Ray SK; Wang G; Purohit S; Banik NL; Dasgupta S
Neurochem Res; 2017 Oct; 42(10):2755-2768. PubMed ID: 28474276
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination.
Davis DL; Mahawar U; Pope VS; Allegood J; Sato-Bigbee C; Wattenberg BW
J Lipid Res; 2020 Apr; 61(4):505-522. PubMed ID: 32041816
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
Tegla CA; Cudrici C; Rus V; Ito T; Vlaicu S; Singh A; Rus H
J Neuroimmunol; 2009 Aug; 213(1-2):3-11. PubMed ID: 19577811
[TBL] [Abstract][Full Text] [Related]
8. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
10. The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders.
Giussani P; Prinetti A; Tringali C
J Neurochem; 2021 Feb; 156(4):403-414. PubMed ID: 33448358
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis.
Jana A; Pahan K
J Neuroimmune Pharmacol; 2007 Jun; 2(2):184-93. PubMed ID: 18040843
[TBL] [Abstract][Full Text] [Related]
12. Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes.
Jana M; Pahan K
Free Radic Biol Med; 2005 Sep; 39(6):823-31. PubMed ID: 16109311
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids in atherosclerosis and vascular biology.
Chatterjee S
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipids: important players in multiple sclerosis.
Halmer R; Walter S; Faßbender K
Cell Physiol Biochem; 2014; 34(1):111-8. PubMed ID: 24977485
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation.
Roggeri A; Schepers M; Tiane A; Rombaut B; van Veggel L; Hellings N; Prickaerts J; Pittaluga A; Vanmierlo T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066042
[TBL] [Abstract][Full Text] [Related]
16. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis.
Coelho RP; Saini HS; Sato-Bigbee C
Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):139-44. PubMed ID: 19808013
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?
Singh IN; Hall ED
J Neurosci Res; 2008 May; 86(7):1419-33. PubMed ID: 18058948
[TBL] [Abstract][Full Text] [Related]
19. Intra- and intercellular trafficking in sphingolipid metabolism in myelination.
Wattenberg BW
Adv Biol Regul; 2019 Jan; 71():97-103. PubMed ID: 30497846
[TBL] [Abstract][Full Text] [Related]
20. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]